Skip to main content

Rathbones Group PLC

Position in ADAPY — Adaptimmune Therapeutics PLC

CIK 1351991 Liverpool, X0

Position in ADAPY

as of Dec 31, 2025 · filed Feb 6, 2026
Position Value
$11,253
-$45,013 QoQ
Shares Held
432,818
0.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADAPY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rathbones Group PLC holds $10,663,603 across 18 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ADAPY

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $11,253 432,818
2025-09-30 $56,266 432,818
2025-06-30 $103,876 432,818
2025-03-31 $85,265 432,818
2024-12-31 $233,288 432,818
2024-09-30 $411,177 432,818
2024-06-30 $421,997 432,818
2024-03-31 $683,852 432,818
2023-12-31 $343,224 432,818
2023-09-30 $337,598 432,818
2023-06-30 $400,356 432,818
2023-03-31 $471,771 432,818
2022-12-31 $631,914 432,818
2022-09-30 $465,279 432,818
2022-06-30 $735,790 432,818
2022-03-31 $891,605 432,818
2021-12-31 $1,623,067 432,818
2021-09-30 $2,238,201 432,921
2021-06-30 $1,844,243 432,921
2021-03-31 $2,298,810 432,921
2020-12-31 $2,333,444 432,921
2020-09-30 $3,454,709 432,921
2020-06-30 $4,433,639 442,921
2020-03-31 $1,084,880 398,853